ADRENAL
2018
Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock
In 3,800 mechanically ventilated patients with septic shock, hydrocortisone 200 mg/day did not reduce 90-day mortality versus placebo, but accelerated shock reversal and discharge.
Result
Efficacy: 90-day all-cause mortalityOR 0.95 (95% CI 0.82-1.10) · P = 0.50
Below 1 favours hydrocortisone 200 mg/day, above 1 favours placebo.
- Absolute difference
- 0.9 points
The absolute difference is derived from the event rates.
Also reported: Faster shock reversal (HR 1.32); shorter ICU and ventilation.
- Subtopic
- Steroids
- Design
- Double-blind RCT, ANZICS
- Relevance
- Important: one of several pillars.
- Also listed in
- Sepsis & septic shock
- Source
- Venkatesh B, et al. N Engl J Med. 2018;378(9):797-808.doi 10.1056/NEJMoa1705835
Discussion & critique
Defines the modern indication: hydrocortisone for haemodynamic and ventilator weaning, not for mortality alone.